Bivalirudin is a new, direct thrombin inhibitor. We investigated the extracorporeal elimination rate of different hemofilters and one plasmapheresis filter for bivalirudin. Our data show that bivalirudin can be effectively eliminated via hemofiltration and plasmapheresis, although there were significant differences in the elimination rates among the filter systems investigated.
|Number of pages||4|
|Journal||Anesthesia and Analgesia|
|Publication status||Published - 1 May 2003|
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine